BioNTech SE
BNTXNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $22.85B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $79.52$124.00
- Volume (live)
- -
- Avg. volume (3M)
- 948.84K
BioNTech SE (BNTX) Stock Price & Financial Analysis
BioNTech SE Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $87.36 - $90.14 |
|---|---|
| 52-Week High | $124.00 |
| 52-Week Low | $79.52 |
| Open | $90.14 |
| Volume (last close) | 1.10M |
| Average Volume (3M) | 948.84K |
| Revenue (TTM) | 2.98B |
|---|---|
| Net Income (TTM) | -1.90B |
| Free Cash Flow (TTM) | 500.70M |
| EPS (TTM) | −$7.66 |
| Profit Margin | -63.64% |
| Operating Margin | -46.90% |
| Return on Equity (ROE) | -9.50% |
| Debt to Equity | 0.02 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Jun 2, 2022 |
| Market Cap | 22.85B |
|---|---|
| Shares Outstanding | 253.33M |
| Price to Sales (P/S) | 7.67 |
| Price to Book (P/B) | 1.14 |
| EV/EBITDA | -12.41 |
| 50-Day MA | $98.89 |
|---|---|
| 200-Day MA | $97.74 |
| 1-Year Change | −14.21% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
BioNTech SE at a Glance
As of the Oct 16, 2026 close, BioNTech SE (BNTX) has a market capitalization of $22.85B. The stock trades at 7.7× sales. Over the trailing twelve months it lost $1.90B on revenue of $2.98B and generated $500.70M of free cash flow. Revenue fell 8.2% year over year.
As of its latest reported balance sheet, it holds $10.95B in cash and securities against $355.27M of debt, a net cash position of $10.59B.
BioNTech SE does not currently pay a dividend.
The share price is down 14.2% over the past year. At $87.71 (the Oct 16, 2026 close) it sits within its 52-week range of $79.52 to $124.00, below its 200-day moving average of $97.74.
Based on 16 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $126.86, 44.6% above the Oct 16, 2026 close.
Frequently Asked Questions About BioNTech SE
What is the current stock price for BNTX?
As of the Oct 16, 2026 close, BNTX stock trades at $87.71. The 52-week range is $79.52–$124.00, with a day range of $87.36–$90.14.
What is the P/E ratio for BNTX?
The P/E ratio (Price-to-Earnings) for BNTX is shown in the Key Statistics section. This valuation metric helps compare BioNTech SE to industry peers.
Does BNTX pay dividends?
BioNTech SE does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BNTX?
Based on ratings from 16 professional analysts over the last 90 days, the consensus for BNTX is Buy. The average 12-month price target is $126.86, a 44.6% upside from the Oct 16, 2026 close of $87.71.
What is the market cap of BNTX?
As of the Oct 16, 2026 close, BioNTech SE's market capitalization is $22.22B, classifying it as a large-cap company. BioNTech SE operates in the Healthcare sector within the Biotechnology industry.